Skip to main content
Home
Search
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
Search General Info
Search Education
Search Partnering Companies
×
×
Search General Info
Search
×
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
BIO Digital
Speakers & Presenters
Meet the experts speaking on our world-class education program.
June 10-11 & 14-18, 2021
Search
Event Menu
Event Menu
About
Attendee Snapshot
Event Announcements
Frequently Asked Questions
Plan
Registration
Promote
NEW Innovation Stage
Become a Sponsor
Global Marketplace
Company Presentations
Start-Up Stadium
Academic Campus
Learn
Interactive Education
Partner
BIO One-on-One Partnering™
Catch Up From 2020
2020 Partnering Companies
2020 Sessions
2020 Speakers
2020 By the Numbers
General Info
Education
Partnering Companies
×
Search General Info
Search
Search Education
Session Title
Session Keywords
Speaker Name
Search
×
Search Partnering Companies
Company Name
City
State
Country/Region
Argentina
Australia
Austria
Belgium
Brazil
Canada
Chile
China
Colombia
Costa Rica
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India
Indonesia
Ireland
Israel
Italy
Japan
Lithuania
Luxembourg
Malaysia
Mauritius
Mexico
Netherlands
New Zealand
Norway
Poland
Portugal
Puerto Rico
Russia
Singapore
Slovenia
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Turkey
Ukraine
United Arab Emirates
United Kingdom
United States
Uruguay
Search
2020 BIO Digital Thought Leaders
All Speakers
Search
Filter
Session Types & Networking
Focus Areas
Interests
Company Presentations
Reset
Apply Filter
×
By Count
|
Alphabetical
Company Presentations
(341)
On Demand Sessions
(303)
Interactive Sessions
(124)
Interactive Super Sessions
(41)
Interactive Special Programs
(29)
Start-Up Stadium
(27)
Global Innovation Hubs
(24)
Interactive Plenaries
(22)
On Demand Special Programs
(17)
Interactive Fireside Chat
(10)
BioProcess International Theater
(5)
Show All
×
By Count
|
Alphabetical
COVID-19
(93)
Business Development and Finance
(51)
Digital Health
(46)
Oncology
(38)
Orphan and Rare Diseases
(34)
Infectious Disease and Vaccines
(32)
Value‚ Patient Access and Reimbursement
(28)
Brain Health
(27)
Personalized Medicine and Diagnostics
(26)
Next Generation Biotherapeutics
(23)
Emerging Opportunities in Global Markets
(21)
Cell & Gene Therapies and Genome Editing
(21)
Patient Advocacy
(17)
Highly Prevalent Chronic Diseases
(15)
Intellectual Property
(13)
Translational Research
(9)
Workforce Development
(9)
Emerging Therapies
(5)
Emerging Techniques, Technologies and Strategies
(1)
Show All
×
By Count
|
Alphabetical
Therapeutics
(126)
Oncology
(99)
COVID-19
(90)
Personalized Medicine
(81)
Preclinical/Research
(81)
Biologics
(76)
Business Development
(76)
CNS/Neurological
(73)
Small Molecules
(70)
Immunology
(69)
Gene/Cell Therapy
(64)
Infectious Diseases
(61)
Diagnostics
(60)
Genomics
(60)
Neurological Disease
(57)
Drug Delivery
(55)
Digital Health
(52)
Medical Devices
(47)
Cell Biology
(44)
Inflammatory Disease
(43)
Screening
(42)
Biomanufacturing
(41)
Translational Research
(41)
Vaccines
(40)
Regulatory Innovation
(40)
Molecular Diagnostics
(39)
Bioinformatics
(39)
Regenerative Medicine
(38)
Metabolic Diseases
(37)
Genetic Disorders
(35)
Intellectual Property
(35)
Contract Research
(34)
Cardiovascular
(33)
Research Tools
(32)
Autoimmune Disease
(31)
Immune Disorder
(31)
Brain Health
(30)
Stem Cell Research
(29)
Gastroenterology
(28)
Musculoskeletal
(26)
Hematology
(25)
Contract Manufacturing
(25)
Proteomics
(25)
Ophthalmology
(25)
Tissue Engineering
(25)
Respiratory
(24)
Transplant Medicine
(22)
Degeneration
(21)
Endocrinology
(20)
Pain Management
(20)
Gene Editing
(20)
Mental Health
(20)
Biobased Products
(19)
Renal
(19)
Nanotechnology
(18)
Urology
(17)
Workforce Development
(17)
Functional Genetics
(17)
Biodefense
(16)
Regulatory Science
(15)
Opioids
(15)
Pulmonary
(15)
Pharmacogenomics
(14)
Psychiatric
(14)
Reproductive Medicine
(13)
Dermatology
(13)
Imaging
(12)
Genitourinary
(12)
Transgenics
(12)
Genetically-enhanced Microbes
(12)
Ocuylar
(11)
One Health
(11)
Prophylaxis
(11)
Diversity
(10)
Nutraceuticals
(10)
Chemicals
(9)
Gynecology and obstetrics
(9)
Plant-made Pharmaceuticals
(8)
Biocatalysis
(8)
Multiline Global Biopharma
(8)
Bio-Energy
(7)
Nutritional Disorder
(7)
Aquaculture
(7)
Animal-made Pharmaceuticals
(7)
Toxicity and Intoxication
(6)
Micro Arrays
(6)
Personal Care
(6)
Growth Disorder
(5)
Industrial Chemicals
(5)
Industrial Enzymes
(5)
Microfluidics
(5)
Food Additives
(4)
Show All
×
Company Type
Privately Funded Company
(230)
Publicly Traded Company
(80)
Advocacy/Non-Profit/Other
(29)
Show All
Main Therapeutic Focus
Oncology
(67)
CNS/Neurological
(34)
Other
(31)
Multiple Therapeutics
(30)
Platform for Therapeutics
(19)
Tools/Drug Development Support Tech
(17)
Gene/Cell Therapy
(15)
Contract Research Organization
(12)
Infectious Diseases
(11)
Digital Health
(11)
Orphan/Rare Diseases
(9)
Contract Manufacturing Organization
(9)
Regenerative Medicine
(8)
Metabolic Diseases
(8)
Ophthalmology
(7)
Diagnostics
(6)
Gastrointestinal
(5)
Inflammation
(5)
Medical Devices
(5)
Dermatology
(4)
Immunology
(4)
Multiline Global Biopharma
(4)
Non-Profit/Patient Advocacy Group
(4)
Cardiovascular
(4)
Pain Management
(3)
COVID-19
(2)
Industrial & Environmental
(2)
Reproductive/Sexual Health
(2)
Respiratory
(2)
Food & Agriculture
(1)
Renewable Chemicals
(1)
Show All
Development Phase of Primary Product
Pre-Clinical
(92)
Other/Not Applicable
(67)
Phase I
(33)
Phase II
(33)
Multiple Products in Market
(33)
Phase III
(28)
Discovery
(13)
NDA Preparation / In Review
(9)
Phase IV
(1)
Show All
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
All Speakers
Search
Filter
Filter by letter
Please Select ...
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
×
Filter Speakers
Session Types & Networking
Please Select ...
Company Presentations (341)
On Demand Sessions (303)
Interactive Sessions (124)
Interactive Super Sessions (41)
Interactive Special Programs (29)
Start-Up Stadium (27)
Global Innovation Hubs (24)
Interactive Plenaries (22)
On Demand Special Programs (17)
Interactive Fireside Chat (10)
BioProcess International Theater (5)
Focus Areas
Please Select ...
COVID-19 (93)
Business Development and Finance (51)
Digital Health (46)
Oncology (38)
Orphan and Rare Diseases (34)
Infectious Disease and Vaccines (32)
Value‚ Patient Access and Reimbursement (28)
Brain Health (27)
Personalized Medicine and Diagnostics (26)
Next Generation Biotherapeutics (23)
Emerging Opportunities in Global Markets (21)
Cell & Gene Therapies and Genome Editing (21)
Patient Advocacy (17)
Highly Prevalent Chronic Diseases (15)
Intellectual Property (13)
Translational Research (9)
Workforce Development (9)
Emerging Therapies (5)
Emerging Techniques, Technologies and Strategies (1)
Interests
Please Select ...
Therapeutics (126)
Oncology (99)
COVID-19 (90)
Personalized Medicine (81)
Preclinical/Research (81)
Biologics (76)
Business Development (76)
CNS/Neurological (73)
Small Molecules (70)
Immunology (69)
Gene/Cell Therapy (64)
Infectious Diseases (61)
Diagnostics (60)
Genomics (60)
Neurological Disease (57)
Drug Delivery (55)
Digital Health (52)
Medical Devices (47)
Cell Biology (44)
Inflammatory Disease (43)
Screening (42)
Biomanufacturing (41)
Translational Research (41)
Vaccines (40)
Regulatory Innovation (40)
Molecular Diagnostics (39)
Bioinformatics (39)
Regenerative Medicine (38)
Metabolic Diseases (37)
Genetic Disorders (35)
Intellectual Property (35)
Contract Research (34)
Cardiovascular (33)
Research Tools (32)
Autoimmune Disease (31)
Immune Disorder (31)
Brain Health (30)
Stem Cell Research (29)
Gastroenterology (28)
Musculoskeletal (26)
Hematology (25)
Contract Manufacturing (25)
Proteomics (25)
Ophthalmology (25)
Tissue Engineering (25)
Respiratory (24)
Transplant Medicine (22)
Degeneration (21)
Endocrinology (20)
Pain Management (20)
Gene Editing (20)
Mental Health (20)
Biobased Products (19)
Renal (19)
Nanotechnology (18)
Urology (17)
Workforce Development (17)
Functional Genetics (17)
Biodefense (16)
Regulatory Science (15)
Opioids (15)
Pulmonary (15)
Pharmacogenomics (14)
Psychiatric (14)
Reproductive Medicine (13)
Dermatology (13)
Imaging (12)
Genitourinary (12)
Transgenics (12)
Genetically-enhanced Microbes (12)
Ocuylar (11)
One Health (11)
Prophylaxis (11)
Diversity (10)
Nutraceuticals (10)
Chemicals (9)
Gynecology and obstetrics (9)
Plant-made Pharmaceuticals (8)
Biocatalysis (8)
Multiline Global Biopharma (8)
Bio-Energy (7)
Nutritional Disorder (7)
Aquaculture (7)
Animal-made Pharmaceuticals (7)
Toxicity and Intoxication (6)
Micro Arrays (6)
Personal Care (6)
Growth Disorder (5)
Industrial Chemicals (5)
Industrial Enzymes (5)
Microfluidics (5)
Food Additives (4)
Company Presentations
Please Select ...
Privately Funded Company (230)
Publicly Traded Company (80)
Advocacy/Non-Profit/Other (29)
Oncology (67)
CNS/Neurological (34)
Other (31)
Multiple Therapeutics (30)
Platform for Therapeutics (19)
Tools/Drug Development Support Tech (17)
Gene/Cell Therapy (15)
Contract Research Organization (12)
Infectious Diseases (11)
Digital Health (11)
Orphan/Rare Diseases (9)
Contract Manufacturing Organization (9)
Regenerative Medicine (8)
Metabolic Diseases (8)
Ophthalmology (7)
Diagnostics (6)
Gastrointestinal (5)
Inflammation (5)
Medical Devices (5)
Dermatology (4)
Immunology (4)
Multiline Global Biopharma (4)
Non-Profit/Patient Advocacy Group (4)
Cardiovascular (4)
Pain Management (3)
COVID-19 (2)
Industrial & Environmental (2)
Reproductive/Sexual Health (2)
Respiratory (2)
Food & Agriculture (1)
Renewable Chemicals (1)
Pre-Clinical (92)
Other/Not Applicable (67)
Phase I (33)
Phase II (33)
Multiple Products in Market (33)
Phase III (28)
Discovery (13)
NDA Preparation / In Review (9)
Phase IV (1)
Apply
Reset
×
×
Search Speakers
Speaker Name
Country/Region
Australia
Austria
Belgium
Canada
China
Costa Rica
Denmark
France
Germany
Hong Kong
Hungary
India
Israel
Italy
Japan
Korea, Republic of
Luxembourg
Netherlands
New Zealand
Norway
Poland
Spain
Sweden
Switzerland
Taiwan
United Kingdom
United States
Company
Search
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Karen Fallen
HEAD OF MAMMALIAN AND MICROBIAL DEVELOPMENT AND MANUFACTURING, LONZA
Lonza Pharma & Biotech
Slough, United Kingdom
Eric Fallon
GLOBAL HEAD OF MANUFACTURING SCIENCE AND TECHNOLOGY, DRUG SUBSTANCE, GENENTECH, A MEMBER OF THE ROCHE GROUP
Discover/Develop: But How Will you Manufacture Your Therapeutic?
Erik Falvey
SR BUSINESS DEVELOPMENT DIRECTOR, IDDI
IDDI
Paris, France
Ronald Farquhar
CEO, MORNINGSIDE BIOPHARMA ADVISORY
Morningside Biopharma Advisory (MBA)
Concord, Massachusetts, United States
Anthony Fauci, MD
DIRECTOR, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES, NATIONAL INSTITUTES OF HEALTH
A Way Forward: Winning the War on COVID through Vaccines
Denise Faustman
HEAD OF IMMUNOBIOLOGY LAB, MASSACHUSETTS GENERAL HOSPITAL
Future of IO Checkpoint Combinations
Charlestown, Massachusetts, United States
Phil Febbo, MD
CMO, ILLUMINA
Fireside Chat with Dr. Phil Febbo, Chief Medical Officer, Illumina
Vic Fedeli
ONTARIO’S MINISTER OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE, MINISTRY OF ECONOMIC DEVELOPMENT, JOB CREATION AND TRADE
Ontario, Canada: Imagination is in our DNA
Stacy Feld
HEAD, JOHNSON & JOHNSON INNOVATION, WEST NORTH AMERICA, AUSTRALIA& NEW ZEALAND, JOHNSON & JOHNSON INNOVATION CENTER
Johnson & Johnson
United States
PETER FELDMAN
CEO, ARBOR LIFE LABS
ARBOR LIFE LABS
TORONTO, Ontario, Canada
Steven Ferguson, CLP, MBA
SPECIAL ADVISOR, NIH OFFICE OF TECHNOLOGY TRANSFER
Many Happy Returns: Federal Labs as Commercialization Partners
Rockville, Maryland, United States
Stephanie Fertig
HHS SMALL BUSINESS PROGRAM LEAD, NATIONAL INSTITUTES OF HEALTH (NIH)
The Key Role of NIH in the Product Development Pipeline
United States
Justin Field
SVP OF GOVERNMENT AFFAIRS, NVCA
Federal Economic Recovery Efforts for Small Biotechnology Companies
Michael Fine
MEDICAL DIRECTOR, HEALTHNET
Activating the Value of RWD/RWE in a COVID-19 World
Huntington Beach, California, United States
Simone Fishburn, PhD
VICE PRESIDENT AND EDITOR IN CHIEF, BIOCENTURY
The Next Generation of Medicine: Cell Therapies, Gene Therapies and Beyond
Fireside Chat with Mathai Mammen, MD, PhD, Global Head, Research and Development, Janssen Pharmaceutical Companies of Johnson & Johnson
Redwood City, California, United States
Wainwright Fishburn
PARTNER, COOLEY LLP
Investors Corner: Digital Health Funding Outlook - Raising Money During Economic Uncertainty
San Diego, California, United States
Michael Fitzhugh
NEWS EDITOR, BIOWORLD, CLARIVATE
'N of Few' - Clinical Trial Design for Small Cohorts
Berkeley, California, United States
Suzanne Fitzpatrick, PhD
SENIOR ADVISOR, TOXICOLOGY , THE U.S. FOOD AND DRUG ADMINISTRATION
Organs-on-a-Chip and AI: Realizing Potential Efficiencies in Drug Discovery and Development
Derwood, Maryland, United States
Kyle Flickinger
VICE PRESIDENT, BIO PHARMACEUTICAL SOLUTIONS, DEEP LENS
Deep Lens, Inc.
Chester Springs, Pennsylvania, United States
Vincent Forster
CEO, VERSANTIS
Versantis
Zurich, Switzerland
Pierre-Alexandre Fournier
CO-FOUNDER & CEO, HEXOSKIN
Can AI Prevent Epidemics?
Canada
Nicholas Franco, BSc, MBA
EVP & CHIEF BUSINESS DEVELOPMENT OFFICER, ACTELION PHARMACEUTICALS LTD, A JANSSEN PHARMACEUTICAL COMPANY OF JOHNSON & JOHNSON
Is It Time to Reconsider M&A’s Role in Portfolio Building?
Allschwil, Switzerland
John Fraser, MD, PhD
DIRECTOR, CRITICAL CARE RESEARCH GROUP, THE PRINCE CHARLES HOSPITAL AND THE UNIVERSITY OF QUEENSLAND
Can AI Prevent Epidemics?
Australia
Marlin Frechette
CORPORATE COMPLIANCE & QUALITY OFFICER, FUJIFILM IRVINE SCIENTIFIC
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
California, United States
Mark Freedman, Bchir, BSc, MBA
CEO & DIRECTOR, SUNREGEN HEALTHCARE AG
SunRegen Healthcare AG
Allschwil, Switzerland
Danielle Friend, PhD
SENIOR DIRECTOR, SCIENCE AND REGULATORY AFFAIRS, BIOTECHNOLOGY INNOVATION ORGANIZATION
Race Against the Clock: Bringing New Cell and Gene Therapies to Market
Advancing Rare Disease Diagnosis and Drug Development Through Partnership
United States
Adi Frish
SENIOR VP BUSINESS DEVELOPMENT AND LICENSING, REDHILL BIOPHARMA
RedHill Biopharma
Tel Aviv, Israel
Tom Frohlich
CHIEF BUSINESS OFFICER, CHINOOK THERAPEUTICS
Precision Medicine Outside Oncology: One Size Does Not Fit All
Vancouver , British Columbia, Canada
Claus Crone Fuglsang
CHIEF SCIENCE OFFICER AND SENIOR VICE PRESIDENT OF RESEARCH AND TECHNOLOGY, NOVOZYMES
The Bio Revolution: Innovations transforming economies, societies, and our lives
Bagsvaerd, Denmark
Toshio Fujimoto, MBA, MD
GENERAL MANAGER OF SHONAN HEALTH INNOVATION PARK, TAKEDA PHARMACEUTICAL COMPANY LTD.
How an Innovation Ecosystem Enables Growth During Times of Crisis and Beyond
Fujisawa, Japan
Load More